aMoon Fund
aMoon is a leading healthtech &a; life sciences venture capital firm.
Business Model: B2B
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed aMoon Fund Information
Geographic Data
Address: 34 Yerushalaim Rd
City: Raanana
State: tel aviv district
Zip: 4350110
Country: IL
Financial Info
Stage:
Raised Last:
$0
Raised Total:$1B
Social
Linkedin
Crunchbase
Metrics
6,356,548Website Global Rank
970Website Monthly Traffic
Twitter Followers
Description
aMoon is a leading healthtech &a; life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science to accelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2020 | CuResponse | Series A | 6M |
| 2/2021 | Viracta Therapeutics | Post-IPO Equity | 65M |
| 9/2020 | MiNA Therapeutics | Series A | 29.5M |
| 7/2020 | Nectin Therapeutics | Venture Round | 6M |
| 3/2022 | Satellite Bio | Series A | 0 |
| 2/2020 | AposHealth | Series A | 11M |
| 9/2021 | Eleos Health | Seed Round | 0 |
| 8/2020 | Mobilion Systems | Series B | 35M |
| 6/2019 | DayTwo | Series B | 0 |
| 4/2011 | CartiHeal | Series C | 300k |
| 2/2022 | Scipher Medicine | Series D | 0 |
| 3/2022 | MDClone | Series C | 0 |
| 3/2021 | Scipher Medicine | Series C | 82M |
| 4/2020 | AtaCor Medical | Series B | 0 |
| 3/2022 | PrognomiQ | Venture Round | 0 |
| 5/2021 | DayTwo | Series B | 37.4M |
| 4/2021 | Sera Prognostics | Series E | 0 |
| 8/2019 | MDClone | Series B | 26M |
| 5/2019 | Ayala Pharmaceuticals | Series B | 0 |
| 9/2022 | Lyfegen | Series A | 8M |
| 6/2021 | KAHR medical | Venture Round | 0 |
| 7/2021 | Mobilion Systems | Series C | 0 |
| 1/2020 | Mammoth Biosciences | Series B | 0 |
| 3/2021 | Ibex Medical Analytics | Series B | 0 |
| 12/2019 | Seer | Series D | 55M |
| 8/2017 | Karius | Series A | 59M |
| 9/2019 | Igentify | Equity | 10.5M |
| 11/2022 | Ibex Medical Analytics | Debt Financing | 0 |
| 5/2022 | Ultima Genomics | Venture Round | 0 |
| 11/2022 | Nectin Therapeutics | Series A | 25M |
| 7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
| 4/2021 | AltruBio | Series A | 63M |
| 3/2019 | Theranica | Series B | 35M |
| 8/2022 | Theranica | Series C | 0 |
| 3/2021 | Absci | Venture Round | 0 |
| 12/2019 | NanoGhosts | Venture Round | 5M |
| 2/2022 | Omada Health | Series E | 0 |
| 7/2018 | Nobio | Venture Round | 3.6M |
| 7/2021 | Sentient Med | Pre Seed Round | - |
| 4/2022 | Eleos Health | Series A | 0 |
| 11/2020 | Viracta Therapeutics | Series E | 0 |
| 12/2019 | Vocalis Health | Venture Round | 9M |
| 3/2019 | Ibex Medical Analytics | Series A | 11M |
| 9/2018 | AtaCor Medical | Series A | 9M |
| 9/2020 | PrognomiQ | Venture Round | 0 |
| 10/2020 | SOPHiA GENETICS | Series F | 0 |
| 3/2018 | Medial EarlySign | Series B | 30M |
| 4/2021 | Biosplice Therapeutics | Venture Round | 0 |
| 7/2020 | Seer | Series D | 55M |
| 6/2018 | Zebra Medical Vision | Series C | 30M |
| 5/2022 | Ultima Genomics | Venture Round | 0 |
| 4/2022 | Eleos Health | Series A | 0 |
| 3/2022 | PrognomiQ | Venture Round | 0 |
| 3/2022 | Satellite Bio | Series A | 0 |
| 3/2022 | MDClone | Series C | 0 |
| 2/2022 | Scipher Medicine | Series D | 0 |
| 2/2022 | Omada Health | Series E | 0 |
| 9/2021 | Eleos Health | Seed Round | 0 |
| 7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
| 7/2021 | Mobilion Systems | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
